Mark Savill, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
Address401 Parnassus Ave.
San Francisco CA 94143
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Savill M, Skymba HV, Ragland JD, Niendam T, Loewy RL, Lesh TA, Carter C, Goldman HH. Acceptability of Psychosis Screening and Factors Affecting Its Implementation: Interviews With Community Health Care Providers. Psychiatr Serv. 2018 Apr 02; appips201700392. PMID: 29606073.
      View in: PubMed
    2. Savill M, D'Ambrosio J, Cannon TD, Loewy RL. Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review. Early Interv Psychiatry. 2018 Feb; 12(1):3-14. PMID: 28782283.
      View in: PubMed
    3. Farreny A, Savill M, Priebe S. Correspondence between negative symptoms and potential sources of secondary negative symptoms over time. Eur Arch Psychiatry Clin Neurosci. 2017 Jun 02. PMID: 28577223.
      View in: PubMed
    4. Savill M, Orfanos S, Bentall R, Reininghaus U, Wykes T, Priebe S. The impact of gender on treatment effectiveness of body psychotherapy for negative symptoms of schizophrenia: A secondary analysis of the NESS trial data. Psychiatry Res. 2017 Jan; 247:73-78. PMID: 27871030.
      View in: PubMed
    5. Priebe S, Savill M, Wykes T, Bentall R, Lauber C, Reininghaus U, McCrone P, Mosweu I, Bremner S, Eldridge S, Röhricht F. Clinical effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia: a multicentre randomised controlled trial. Health Technol Assess. 2016 Feb; 20(11):vii-xxiii, 1-100. PMID: 26869182; PMCID: PMC4782808.
    6. Savill M, Priebe S. Letter to the Editor: Concepts and methods when considering negative symptom course: a reply. Psychol Med. 2015 Aug; 45(11):2459-60. PMID: 25919939.
      View in: PubMed
    7. Savill M, Banks C, Khanom H, Priebe S. Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data. Psychol Med. 2015 Jun; 45(8):1613-27. PMID: 25425086.
      View in: PubMed
    8. Barnicot K, Savill M, Bhatti N, Priebe S. A pragmatic randomised controlled trial of dialectical behaviour therapy: effects on hospitalisation and post-treatment follow-up. Psychother Psychosom. 2014; 83(3):192-3. PMID: 24752222.
      View in: PubMed
    9. Priebe S, Savill M, Reininghaus U, Wykes T, Bentall R, Lauber C, McCrone P, Röhricht F, Eldridge S. Effectiveness and cost-effectiveness of body psychotherapy in the treatment of negative symptoms of schizophrenia--a multi-centre randomised controlled trial. BMC Psychiatry. 2013 Jan 14; 13:26. PMID: 23317474; PMCID: PMC3556155.
    10. Katsakou C, Marougka S, Barnicot K, Savill M, White H, Lockwood K, Priebe S. Recovery in Borderline Personality Disorder (BPD): a qualitative study of service users' perspectives. PLoS One. 2012; 7(5):e36517. PMID: 22615776; PMCID: PMC3355153.
    11. Savill M, Jankovic J, Katsakou C, Kallert T, Priebe S. Symptom levels and initial appraisal of hospital treatment in patients with schizophrenia. Psychiatry Res. 2012 Sep 30; 199(2):79-83. PMID: 22565214.
      View in: PubMed
    12. Barnicot K, Katsakou C, Bhatti N, Savill M, Fearns N, Priebe S. Factors predicting the outcome of psychotherapy for borderline personality disorder: a systematic review. Clin Psychol Rev. 2012 Jul; 32(5):400-12. PMID: 22681913.
      View in: PubMed
    Mark's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP